Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jobial
- Development stage
- Unknown
- Lead developer
- MEDcell
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Administration
- Oral
01
Overview
Jobial is a multi-ingredient nutraceutical tablet developed by Medcell Pharma for comprehensive tendon care, tendon repair, and the management of tendinopathy, tendon tears, and tendonitis. It is formulated with a combination of bioactive collagen peptide-I (Tendoforte), protein hydrolysate, chondroitin sulfate, Boswellia serrata extract, bamboo shoot extract (rich in silica), sodium hyaluronate, and a blend of essential vitamins (C, D3, B6, B12) and minerals (magnesium, manganese, zinc). Together, these components work synergistically to enhance tendon elasticity and strength, reduce inflammation and discomfort, maintain joint lubrication, and support overall musculoskeletal health.
- Brand names
- Jobial
02
Targets
ALOX5 (Arachidonate 5-lipoxygenase)
Beyond the preview
Go deeper on Jobial.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jobial.